Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  BB BIOTECH AG    BION   CH0038389992

BB BIOTECH AG (BION)
My previous session
Most popular
  Report  
Real-time Quote. Real-time CHI-X - 01/23 11:30:00 am
67.4 CHF   -0.22%
2013BB BIOTECH AG : quaterly earnings release
2013BB BIOTECH AG : quaterly earnings release
2012BB BIOTECH AG : quaterly earnings release
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
01/17/2019 01/18/2019 01/21/2019 01/22/2019 01/23/2019 Date
69.45(c) 68.3(c) 68.9(c) 67.55(c) 67.6 Last
76 921 149 592 87 246 100 276 67 518 Volume
+0.36% -1.66% +0.88% -1.96% +0.07% Change
More quotes
Financials (CHF)
Sales 2019 -
EBIT 2019 432 M
Net income 2019 275 M
Debt 2019 341 M
Yield 2019 4,69%
Sales 2020 -
EBIT 2020 504 M
Net income 2020 505 M
Debt 2020 475 M
Yield 2020 6,99%
P/E ratio 2019 13,27
P/E ratio 2020 7,32
EV / Sales2019 0
EV / Sales2020 0
Capitalization 3 742 M
More Financials
Company
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and... 
Sector
Holding Companies
Calendar
02/15 | 01:00amEarnings Release
More about the company
Latest news on BB BIOTECH AG
01/18BB BIOTECH : invests gains of M&A transactions in new technologies - dividend of..
EQ
01/18BB BIOTECH : closes the 2018 fiscal year with a loss
EQ
2018BB BIOTECH : enlarges its Board of Directors
EQ
2018BB BIOTECH AG : Investors showed renewed interest in biotech stocks during the t..
EQ
2018BB BIOTECH : reports preliminary results
EQ
2018BB BIOTECH : holds steady in the second quarter
AQ
2018BB BIOTECH : shares hold steady in the second quarter
EQ
2018BB BIOTECH : reports preliminary results for 1H 2018
EQ
2018BB BIOTECH : admitted to the SMIM and SPI Index
EQ
2018BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
More news
Analyst Recommendations on BB BIOTECH AG
More recommendations
Sector news : Holding Companies - NEC
01/15Total Plans Dutch Offshore Gas-Field Sale -Reuters
DJ
01/07CK HUTCHISON : Correction to Temasek Seeking to Sell Part of Its Stake in A.S. W..
DJ
01/07LI KA-SHING : Temasek Seeks to Sell Part of Its Stake in A.S. Watson, Source Say..
DJ
2018GROUPE BRUXELLES LAMBERT : Albert Frere Has Died
DJ
2018ALBERT FRÈRE : Dealmaker Albert Frere, Belgium's richest man, dies aged 92
RE
More sector news : Holding Companies - NEC
Chart BB BIOTECH AG
Duration : Period :
BB BIOTECH AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 70,1  CHF
Spread / Average Target 3,8%
EPS Revisions
Managers
NameTitle
Erich Hunziker Chairman
Clive A. Meanwell Vice Chairman
Klaus Strein Director
Claude Mikkelsen Director-Investor Relations
Felicia Flanigan Senior Biotech Analyst
Sector and Competitors
1st jan.Capitalization (M$)
BB BIOTECH AG15.67%3 751
CK HUTCHISON HOLDINGS LTD3.92%38 437
INVESTOR AB6.42%33 980
INDUSTRIVÄRDEN3.71%9 117
REMGRO LIMITED7.98%7 840
KOC HOLDING AS--.--%7 678